News
A woman who was diagnosed with stage 2 Hodgkin lymphoma has shared the symptoms that led to diagnosis, and discovering she had blood cancer. According to the NHS, Hodgkin Lymphoma is a "relatively ...
A new treatment for Hodgkin lymphoma has been recommended for routine use on the NHS. Around 800 people with the advanced form of blood cancer could benefit, it is believed. The condition develops ...
11d
News Medical on MSNNK cells with bispecific antibody yield high response rates in patients with lymphoma: Clinical trialA novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
A new treatment for Hodgkin lymphoma has been recommended for routine use on the NHS. Around 800 people with the advanced ...
Yago Nieto, MD, PhD, discusses AFM13, how it works, and its effect as a bispecific antibody that targets CD30 and CD16.
Researchers sought to determine whether mosunetuzumab would have long-term efficacy in patients with follicular lymphoma.
There are two types of lymphoma: Hodgkin's lymphoma and non-Hodgkin's lymphoma. Most B-cell lymphomas are non-Hodgkin's lymphoma. B-cell lymphomas come in many types. Some grow quickly and others ...
Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science of addressing critical issues with CAR T cell therapy in patients with ...
Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...
FAYETTE - Doris Irene (Hodgkins) Morris, 85, of Fayette, passed away peacefully on Feb. 16, 2025, at the Augusta Center for ... FAYETTE – Doris Irene (Hodgkins) Morris, 85, of Fayette ...
In this phase 1 trial, patients with heavily pretreated and refractory CD30 + lymphoma were safely treated with donor-cord-blood-derived NK cells that were precomplexed with the anti-CD30 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results